Literature DB >> 6311909

Lethal infection with murine cytomegalovirus after early viral replication in the spleen.

D A Katzenstein, G S Yu, M C Jordan.   

Abstract

In acute lethal murine cytomegalovirus (MCMV) infection the spleen and liver are the principal sites of early viral replication. MCMV titers increase rapidly in the spleen and liver, exceeding 10(6) and 10(5) plaque-forming units (pfu)/g of tissue, respectively, within 96 hr of viral inoculation. Experiments were performed to determine the impact of early splenic viral replication on disease pathogenesis. Splenectomized mice survived acute infection in significantly greater numbers (25 of 34 vs 14 of 33, respectively) than controls and had lower hepatic viral titers (1.9 X 10(4) vs 2.4 X 10(5) pfu/g, respectively). Examination of the spleen by electron microscopy after administration of phagocytic markers demonstrated that macrophages were the predominant site of viral replication. It is concluded that early replication of MCMV in splenic macrophages augments virus-induced hepatic injury and thus contributes to the pathogenesis of lethal MCMV infection.

Entities:  

Mesh:

Year:  1983        PMID: 6311909     DOI: 10.1093/infdis/148.3.406

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections.

Authors:  J A Mercer; C A Wiley; D H Spector
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  Tissue distribution of bovid herpesvirus-4 in inoculated rabbits and its detection by DNA hybridization and polymerase chain reaction.

Authors:  K Naeem; M P Murtaugh; S M Goyal
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

Review 3.  Animal cytomegaloviruses.

Authors:  J Staczek
Journal:  Microbiol Rev       Date:  1990-09

4.  Effective inhibition of K(b)- and D(b)-restricted antigen presentation in primary macrophages by murine cytomegalovirus.

Authors:  Diane M LoPiccolo; Marielle C Gold; Daniel G Kavanagh; Markus Wagner; Ulrich H Koszinowski; Ann B Hill
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

5.  Replication of murine cytomegalovirus in differentiated macrophages as a determinant of viral pathogenesis.

Authors:  L K Hanson; J S Slater; Z Karabekian; H W Virgin; C A Biron; M C Ruzek; N van Rooijen; R P Ciavarra; R M Stenberg; A E Campbell
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

6.  Pulmonary macrophage function during experimental cytomegalovirus interstitial pneumonia.

Authors:  S A Miller; F J Bia; D L Coleman; H L Lucia; K R Young; R K Root
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

7.  Pathogenesis of acute murine cytomegalovirus infection in resistant and susceptible strains of mice.

Authors:  J A Mercer; D H Spector
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

8.  An animal model for therapeutic intervention studies of CMV infection in the immunocompromised host.

Authors:  F S Stals; F Bosman; C P van Boven; C A Bruggeman
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

9.  Effective inhibition in animals of viral pathogenesis by a ribozyme derived from RNase P catalytic RNA.

Authors:  Yong Bai; Phong Trang; Hongjian Li; Kihoon Kim; Tianhong Zhou; Fenyong Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-28       Impact factor: 11.205

Review 10.  MHC class I immune evasion in MCMV infection.

Authors:  Carmen M Doom; Ann B Hill
Journal:  Med Microbiol Immunol       Date:  2008-03-11       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.